Annual Interest Expense
$24.00 K
-$8300.00-25.70%
30 September 2022
Summary:
NeuBase Therapeutics annual interest expense is currently $24.00 thousand, with the most recent change of -$8300.00 (-25.70%) on 30 September 2022. During the last 3 years, it has fallen by -$8300.00 (-25.70%).NBSE Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$100.00
-$600.00-85.71%
30 September 2023
Summary:
NeuBase Therapeutics quarterly interest expense is currently $100.00, with the most recent change of -$600.00 (-85.71%) on 30 September 2023.NBSE Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$5100.00
-$2600.00-33.77%
30 September 2023
Summary:
NeuBase Therapeutics TTM interest expense is currently $5100.00, with the most recent change of -$2600.00 (-33.77%) on 30 September 2023.NBSE TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -25.7% | -99.2% | -84.3% |
| 5 y5 years | -81.4% | - | - |
NBSE Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -81.4% | -99.3% | -87.5% |
NeuBase Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $100.00(-85.7%) | $5100.00(-33.8%) |
| June 2023 | - | $700.00(-70.8%) | $7700.00(-21.4%) |
| Mar 2023 | - | $2400.00(+26.3%) | $9800.00(-8.4%) |
| Dec 2022 | - | $1900.00(-29.6%) | $10.70 K(-55.4%) |
| Sept 2022 | $24.00 K(-25.7%) | $2700.00(-3.6%) | $24.00 K(-30.2%) |
| June 2022 | - | $2800.00(-15.2%) | $34.40 K(-0.9%) |
| Mar 2022 | - | $3300.00(-78.3%) | $34.70 K(-8.4%) |
| Dec 2021 | - | $15.20 K(+16.0%) | $37.90 K(+17.0%) |
| Sept 2021 | $32.30 K(+319.5%) | $13.10 K(+322.6%) | $32.40 K(+36.1%) |
| June 2021 | - | $3100.00(-52.3%) | $23.80 K(+6.7%) |
| Mar 2021 | - | $6500.00(-33.0%) | $22.30 K(+38.5%) |
| Dec 2020 | - | $9700.00(+115.6%) | $16.10 K(+109.1%) |
| Sept 2020 | $7700.00(-94.0%) | $4500.00(+181.3%) | $7700.00(+140.6%) |
| June 2020 | - | $1600.00(+433.3%) | $3200.00(+100.0%) |
| Mar 2020 | - | $300.00(-76.9%) | $1600.00(+23.1%) |
| Dec 2019 | - | $1300.00(-63.9%) | $1300.00(-75.0%) |
| Sept 2019 | $129.00 K(+2644.7%) | - | - |
| June 2014 | - | $3600.00(>+9900.0%) | $5200.00(+13.0%) |
| Mar 2014 | - | $0.00(-100.0%) | $4600.00(0.0%) |
| Dec 2013 | - | $500.00(-54.5%) | $4600.00(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | $4700.00(+161.1%) | $1100.00(-63.3%) | $4700.00(+4.4%) |
| June 2013 | - | $3000.00(>+9900.0%) | $4500.00(+87.5%) |
| Mar 2013 | - | $0.00(-100.0%) | $2400.00(0.0%) |
| Dec 2012 | - | $600.00(-33.3%) | $2400.00(+33.3%) |
| Sept 2012 | $1800.00(-25.0%) | $900.00(0.0%) | $1800.00(+100.0%) |
| June 2012 | - | $900.00(>+9900.0%) | $900.00(+800.0%) |
| Mar 2012 | - | $0.00(0.0%) | $100.00(-66.7%) |
| Dec 2011 | - | $0.00(0.0%) | $300.00(-88.0%) |
| Sept 2011 | $2400.00(-88.8%) | $0.00(-100.0%) | $2500.00(-46.8%) |
| June 2011 | - | $100.00(-50.0%) | $4700.00(-33.8%) |
| Mar 2011 | - | $200.00(-90.9%) | $7100.00(-26.8%) |
| Dec 2010 | - | $2200.00(0.0%) | $9700.00(-54.9%) |
| Sept 2010 | $21.50 K(-16.7%) | $2200.00(-12.0%) | $21.50 K(-27.4%) |
| June 2010 | - | $2500.00(-10.7%) | $29.60 K(-27.5%) |
| Mar 2010 | - | $2800.00(-80.0%) | $40.80 K(+2.5%) |
| Dec 2009 | - | $14.00 K(+35.9%) | $39.80 K(+54.3%) |
| Sept 2009 | $25.80 K(>+9900.0%) | $10.30 K(-24.8%) | $25.80 K(+66.5%) |
| June 2009 | - | $13.70 K(+661.1%) | $15.50 K(+761.1%) |
| Mar 2009 | - | $1800.00(>+9900.0%) | $1800.00(>+9900.0%) |
| Dec 2008 | - | $0.00 | $0.00 |
| Sept 2008 | $0.00 | - | - |
FAQ
- What is NeuBase Therapeutics annual interest expense?
- What is the all time high annual interest expense for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for NeuBase Therapeutics?
- What is NeuBase Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for NeuBase Therapeutics?
What is NeuBase Therapeutics annual interest expense?
The current annual interest expense of NBSE is $24.00 K
What is the all time high annual interest expense for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual interest expense is $129.00 K
What is NeuBase Therapeutics quarterly interest expense?
The current quarterly interest expense of NBSE is $100.00
What is the all time high quarterly interest expense for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly interest expense is $15.20 K
What is NeuBase Therapeutics TTM interest expense?
The current TTM interest expense of NBSE is $5100.00
What is the all time high TTM interest expense for NeuBase Therapeutics?
NeuBase Therapeutics all-time high TTM interest expense is $40.80 K